Key result
Integrated lipid biomarker signature effectively diagnoses prediabetes and T2DM with ~0.89 peak AUC.
Why the study?
Analyses of lipid metabolic profiles in T2DM have the potential to permit development of an integrated lipid metabolite-based biomarker model facilitating early diagnosis and treatment.
Can an integrated serum lipidomic biomarker signature accurately identify Chinese patients with newly diagnosed prediabetes and T2DM?
Observational (n=533)
Yes
Can an integrated serum lipidomic biomarker signature accurately identify Chinese patients with newly diagnosed prediabetes and T2DM?
A novel 8-lipid biomarker signature accurately identifies newly diagnosed prediabetes and T2DM in Chinese patients, highlighting the role of sphingomyelinase-regulated ceramide homeostasis in diabetes pathogenesis.
Answers are grounded in this paper and cite their sources.
May support lipidomic screening for prediabetes in Chinese adults; leaves open prospective validation and broader applicability.
Introduction Dyslipidemia is a hallmark of T2DM, and as such, analyses of lipid metabolic profiles in affected patients have the potential to permit the development of an integrated lipid metabolite-based biomarker model that can facilitate early patient diagnosis and treatment. Methods Untargeted and targeted lipidomics approaches were used to analyze serum samples from newly diagnosed 93 Chinese participants in discovery cohort and 440 in validation cohort via UHPLC-MS and UHPLC-MS/MS first. The acid sphingomyelinase protein expression was analyzed by Western blot. Results and Discussion Through these analyses, we developed a novel integrated biomarker signature composed of LPC 22:6, PC(16:0/20:4), PE(22:6/16:0), Cer(d18:1/24:0)/SM(d18:1/19:0), Cer(d18:1/24:0)/SM(d18:0/16:0), TG(18:1/18:2/18:2), TG(16:0/16:0/20:3), and TG(18:0/16:0/18:2). The area under the curve (AUC) values for this integrated biomarker signature for prediabetes and T2DM patients were 0.841 (cutoff: 0.565) and 0.894 (cutoff: 0.633), respectively. Furthermore, theresults of western blot analysis of frozen adipose tissue from 3 week (prediabetes) and 12 week (T2DM) Goto–Kakizaki (GK) rats also confirmed that acid sphingomyelinase is responsible for significant disruptions in ceramide and sphingomyelin homeostasis. Network analyses of the biomarkers associated with this biosignature suggested that the most profoundly affected lipid metabolism pathways in the context of diabetes include de novo ceramide synthesis, sphingomyelin metabolism, and additional pathways associated with phosphatidylcholine synthesis. Together, these results offer new biological insights regarding the role of serum lipids in the context of insidious T2DM development, and may offer new avenues for future diagnostic and/or therapeutic research.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2023) conducted an observational in Prediabetes and Type 2 Diabetes Mellitus (n=533). Integrated lipids biomarker signature vs. Healthy controls was evaluated on Diagnostic accuracy (AUC) of integrated biomarker signature for T2DM. An integrated lipid biomarker signature effectively diagnosed prediabetes and type 2 diabetes mellitus with area under the curve values of 0.841 and 0.894, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: